Experience with maintenance rituximab after chemotherapy in patients with low-grade lymphoma

Ayodele Ayoola, Mercedes Terrell, Huzefa Bahrain, Patricia Ford, Michael Auerbach

Research output: Contribution to journalArticlepeer-review

Abstract

In this retrospective analysis of 21 previously untreated patients, long-term rituximab maintenance therapy following R-CHOP chemotherapy was well tolerated and resulted in prolonged progression-free survival, with no relapses.

Original languageEnglish (US)
Pages (from-to)414-417
Number of pages4
JournalCommunity Oncology
Volume7
Issue number9
DOIs
StatePublished - Sep 2010

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Experience with maintenance rituximab after chemotherapy in patients with low-grade lymphoma'. Together they form a unique fingerprint.

Cite this